/Investor DB

GL Ventures — 2021 Investments

3 investments dated 2021 · listed companies and verified rows first · show all

Biohengbioheng.comMar 2021 · $80M

Imviva is a clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases.

BiotechDeep TechHealthtechMedical Devices

Jiangtao Ren(Chief Scientific Officer)Lu Han(Chief Executive Officer)Yajin Ni(Chief Technology Officer)Jan Davidson(Chief Medical Officer)

Co-investorsDecheng CapitalHillhouse CapitalShenzhen Capital Group

Certikcertik.comin𝕏Nov 2021

CertiK is a Web3 security platform that combines formal verification with smart contract audits, penetration testing, on-chain monitoring, AML/compliance tools, and incident response for blockchain projects, exchanges, and wallets.

Crypto & Web3CybersecuritySaaSNew York City, US

Sergey Gorbunov(Co-Founder)Alex Wilke(Co-Founder)Zhong Shao(Founder)inRonghui Gu(Founder)inProfessor Ronghui Gu(Founder)Professor Zhong Shao(Founder)

Co-investors10T FundCandaq Fintech GroupCoatue ManagementCoinbase VenturesContinue CapitalCyberport Hong Kong+17 more

XAGxa.cominMar 2021 · $46M

XAG develops agricultural drones, ground rovers, autopilot consoles, smart fertigation systems, and farm management IoT products for precision farming and intelligent management of water, fertilizer, and pesticides.

AgTechAI & Machine LearningRobotics

Peng Bin(Founder)

Co-investorsSoftBank Vision FundBaiduBaidu CapitalBaidu VenturesSinovation VenturesSoftBank Group

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.